Phase II Study of RC1416 Injection in COPD

Clinical trial NCT07402551 · RECRUITING

Trial details

NCT number: NCT07402551
Sponsor: Nanjing RegeneCore Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2026-03-06
Primary completion: 2028-05-31
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.